NEPH
Nephros, Inc.
Price Chart
Latest Quote
$3.30
+0.01 (+0.30%)
Current Price
| Previous Close | $3.29 |
| Open | $3.32 |
| Day High | $3.33 |
| Day Low | $3.24 |
| Volume | 2,532 |
Stock Information
| Shares Outstanding | 10.86M |
| Total Debt | $968K |
| Cash Equivalents | $4.02M |
| Revenue | $19.12M |
| Net Income | $776K |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Market Cap | $35.83M |
| P/E Ratio | 47.14 |
| EPS (TTM) | $0.07 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $32.78M |
| Sales | $19.12M |
| Income | $776K |
| Book/sh | $0.99 |
| Cash/sh | $0.37 |
| Employees | 36 |
Financial Ratios
| Quick Ratio | 2.98 |
| Current Ratio | 4.55 |
| Debt/Eq | 9.05 |
| EPS Growth TTM | -74.90% |
Returns & Margins
| ROA | 3.31% |
| ROE | 7.76% |
| Gross Margin | 59.95% |
| Operating Margin | 1.86% |
| Profit Margin | 4.06% |
Ownership
| Insider Ownership | 12.87% |
| Institutional Ownership | 49.48% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 33.00 |
| P/S | 1.87 |
| P/B | 3.34 |
Analyst Data
| Recommendation | none |
| Target Price | $7.00 |
Technical Indicators
| SMA20 | $3.42 |
| SMA50 | $3.28 |
| SMA200 | $4.16 |
| RSI | 29.51 |
| ATR | 0.1814 |
| Shares Float | 8.82M |
| Short Float | 0.38% |
| Short Ratio | 0.74 |
| Volatility | 1.50 |
| Rel Volume | 0.22 |
Performance History
| Week | +5.43% |
| Month | -10.57% |
| Quarter | +6.11% |
| 6 Months | -34.91% |
| YTD | -30.53% |
| Year | -34.00% |
| 3 Years | +121.48% |
| 5 Years | -63.33% |
| 10 Years | +35.80% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-23 | $3.30 | 2,900 |
| 2026-06-22 | $3.26 | 2,700 |
| 2026-06-18 | $3.15 | 11,300 |
| 2026-06-17 | $3.20 | 15,400 |
| 2026-06-16 | $3.19 | 34,300 |
| 2026-06-15 | $3.13 | 11,600 |
| 2026-06-12 | $3.34 | 3,400 |
| 2026-06-11 | $3.33 | 1,500 |
| 2026-06-10 | $3.20 | 8,500 |
| 2026-06-09 | $3.25 | 13,500 |
| 2026-06-08 | $3.39 | 12,600 |
| 2026-06-05 | $3.42 | 11,200 |
| 2026-06-04 | $3.59 | 14,500 |
| 2026-06-03 | $3.64 | 8,700 |
| 2026-06-02 | $3.80 | 32,100 |
| 2026-06-01 | $3.69 | 12,300 |
| 2026-05-29 | $3.66 | 4,900 |
| 2026-05-28 | $3.70 | 7,600 |
| 2026-05-27 | $3.60 | 28,600 |
| 2026-05-26 | $3.58 | 20,800 |
About Nephros, Inc.
Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in foodservice and hospitality, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water; reduce biofilm and scale build-up; and remove cysts, particulates, and lead from water systems. It markets its products to food service and hospitality sectors including quick-service restaurants, convenience stores, and restaurants. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.
đ° Latest News
US$7.00 - That's What Analysts Think Nephros, Inc. (NASDAQ:NEPH) Is Worth After These Results
Simply Wall St. âĸ 2026-05-11T11:50:14Z
Nephros, Inc. Q1 2026 Earnings Call Summary
Moby âĸ 2026-05-08T12:30:00Z
3 Promising Penny Stocks With Market Caps Under $200M
Simply Wall St. âĸ 2026-04-30T18:05:22Z
Nephros Inc (NEPH) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amid Margin Pressures
GuruFocus.com âĸ 2026-03-14T01:02:44ZNephros (NEPH) Q4 2025 Earnings Call Transcript
Motley Fool âĸ 2026-03-13T13:25:22Z
Nephros, Inc. Q4 2025 Earnings Call Summary
Moby âĸ 2026-03-13T12:30:00Z
Promising Penny Stocks To Consider In February 2026
Simply Wall St. âĸ 2026-02-19T18:05:13Z
Spotlight On Silence Therapeutics And 2 Other Promising Penny Stocks
Simply Wall St. âĸ 2026-02-19T12:05:06Z
Aureus Greenway Holdings And 2 Other Promising Penny Stocks To Watch
Simply Wall St. âĸ 2026-02-18T12:04:58Z
Gaia Leads The Charge With 2 Other Promising Penny Stocks
Simply Wall St. âĸ 2026-02-17T18:05:44Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $7,165,000 | $5,437,000 | $5,833,000 | $5,111,000 |
| Cost Of Revenue | $7,164,000 | $5,439,000 | $5,833,000 | $5,244,000 |
| Total Revenue | $18,789,000 | $14,162,000 | $14,238,000 | $9,975,000 |
| Operating Revenue | $18,789,000 | $14,162,000 | $14,238,000 | $9,975,000 |
| Expenses | ||||
| Interest Expense | $1,000 | $1,000 | $2,000 | $20,000 |
| Total Expenses | $17,643,000 | $14,156,000 | $15,831,000 | $14,310,000 |
| Other Income Expense | $-78,000 | $-10,000 | $-44,000 | $64,000 |
| Net Non Operating Interest Income Expense | $138,000 | $93,000 | $62,000 | $-6,000 |
| Interest Expense Non Operating | $1,000 | $1,000 | $2,000 | $20,000 |
| Operating Expense | $10,479,000 | $8,717,000 | $9,998,000 | $9,066,000 |
| Other Non Operating Income Expenses | - | - | $-44,000 | $64,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $1,194,000 | $74,000 | $-1,575,000 | $-4,553,000 |
| Net Interest Income | $138,000 | $93,000 | $62,000 | $-6,000 |
| Interest Income | $139,000 | $94,000 | $64,000 | $14,000 |
| Normalized Income | $1,271,228 | $82,333 | $-1,531,000 | $-4,617,000 |
| Net Income From Continuing And Discontinued Operation | $1,194,000 | $74,000 | $-1,575,000 | $-7,382,000 |
| Total Operating Income As Reported | $1,146,000 | $6,000 | $-1,593,000 | $-4,335,000 |
| Net Income Common Stockholders | $1,194,000 | $74,000 | $-1,575,000 | $-7,382,000 |
| Net Income | $1,194,000 | $74,000 | $-1,575,000 | $-7,382,000 |
| Net Income Including Noncontrolling Interests | $1,194,000 | $74,000 | $-1,575,000 | $-7,106,000 |
| Net Income Continuous Operations | $1,194,000 | $74,000 | $-1,575,000 | $-4,277,000 |
| Pretax Income | $1,206,000 | $89,000 | $-1,575,000 | $-4,277,000 |
| Interest Income Non Operating | $139,000 | $94,000 | $64,000 | $14,000 |
| Operating Income | $1,146,000 | $6,000 | $-1,593,000 | $-4,335,000 |
| Depreciation Amortization Depletion Income Statement | $140,000 | $135,000 | $214,000 | $218,000 |
| Depreciation And Amortization In Income Statement | $140,000 | $135,000 | $214,000 | $218,000 |
| Gross Profit | $11,625,000 | $8,723,000 | $8,405,000 | $4,731,000 |
| Net Income Discontinuous Operations | - | - | $0 | $-2,829,000 |
| Special Income Charges | - | - | - | $0 |
| Per Share | ||||
| Diluted EPS | $0.11 | $0.01 | $-0.15 | $-0.70 |
| Basic EPS | $0.11 | $0.01 | $-0.15 | $-0.70 |
| Other | ||||
| Tax Effect Of Unusual Items | $-772 | $-1,667 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $1,425,000 | $237,000 | $-1,315,000 | $-3,970,000 |
| Total Unusual Items | $-78,000 | $-10,000 | $-44,000 | $64,000 |
| Total Unusual Items Excluding Goodwill | $-78,000 | $-10,000 | $-44,000 | $64,000 |
| Reconciled Depreciation | $139,000 | $137,000 | $214,000 | $351,000 |
| EBITDA (Bullshit earnings) | $1,347,000 | $227,000 | $-1,359,000 | $-3,906,000 |
| EBIT | $1,207,000 | $90,000 | $-1,573,000 | $-4,257,000 |
| Diluted Average Shares | $10,968,063 | $10,609,642 | $10,386,018 | $10,297,134 |
| Basic Average Shares | $10,612,288 | $10,525,197 | $10,386,018 | $10,297,134 |
| Diluted NI Availto Com Stockholders | $1,194,000 | $74,000 | $-1,575,000 | $-7,382,000 |
| Tax Provision | $12,000 | $15,000 | $0 | - |
| Gain On Sale Of Security | $-78,000 | $-10,000 | $-44,000 | $64,000 |
| Research And Development | $1,339,000 | $906,000 | $873,000 | $1,255,000 |
| Selling General And Administration | $9,000,000 | $7,676,000 | $8,911,000 | $7,593,000 |
| Minority Interests | - | - | $0 | $-276,000 |
| Other Special Charges | - | - | - | - |
| Restructuring And Mergern Acquisition | - | - | - | - |
Fetched: 2026-06-23
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $8,961,000 | $7,261,000 | $6,947,000 | $4,008,000 |
| Total Assets | $13,641,000 | $11,210,000 | $11,861,000 | $10,999,000 |
| Total Non Current Assets | $2,418,000 | $2,912,000 | $3,456,000 | $2,738,000 |
| Other Non Current Assets | $50,000 | $50,000 | $86,000 | $54,000 |
| Goodwill And Other Intangible Assets | $1,241,000 | $1,324,000 | $1,411,000 | $1,584,000 |
| Other Intangible Assets | $482,000 | $565,000 | $652,000 | $825,000 |
| Current Assets | $11,223,000 | $8,298,000 | $8,405,000 | $8,261,000 |
| Other Current Assets | $177,000 | $142,000 | $132,000 | $188,000 |
| Inventory | $3,232,000 | $2,615,000 | $2,470,000 | $3,153,000 |
| Receivables | $2,414,000 | $1,781,000 | $1,496,000 | $1,286,000 |
| Accounts Receivable | $2,414,000 | $1,781,000 | $1,496,000 | $1,286,000 |
| Cash Cash Equivalents And Short Term Investments | $5,400,000 | $3,760,000 | $4,307,000 | $3,634,000 |
| Cash And Cash Equivalents | $5,400,000 | $3,760,000 | $4,307,000 | $3,634,000 |
| Allowance For Doubtful Accounts Receivable | - | $-11,000,000 | $-11,000,000 | $0 |
| Gross Accounts Receivable | - | $12,781,000 | $12,496,000 | $1,286,000 |
| Cash Equivalents | - | - | $4,033,000 | $2,036,000 |
| Cash Financial | - | - | $274,000 | $1,598,000 |
| Assets Held For Sale Current | - | - | - | $0 |
| Prepaid Assets | - | - | - | $188,000 |
| Debt | ||||
| Total Debt | $1,063,000 | $1,411,000 | $1,836,000 | $1,093,000 |
| Long Term Debt And Capital Lease Obligation | $672,000 | $1,063,000 | $1,390,000 | $706,000 |
| Current Debt And Capital Lease Obligation | $391,000 | $348,000 | $446,000 | $387,000 |
| Long Term Debt | - | - | - | $1,000 |
| Current Debt | - | - | - | $71,000 |
| Other Current Borrowings | - | - | - | $71,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $3,439,000 | $2,625,000 | $3,503,000 | $2,118,000 |
| Total Non Current Liabilities Net Minority Interest | $672,000 | $1,063,000 | $1,390,000 | $706,000 |
| Current Liabilities | $2,767,000 | $1,562,000 | $2,113,000 | $1,412,000 |
| Payables And Accrued Expenses | $2,376,000 | $1,214,000 | $1,667,000 | $1,025,000 |
| Payables | $1,022,000 | $693,000 | $909,000 | $757,000 |
| Total Tax Payable | $108,000 | $44,000 | $36,000 | $17,000 |
| Accounts Payable | $914,000 | $649,000 | $873,000 | $740,000 |
| Liabilities Heldfor Sale Non Current | - | - | - | $0 |
| Other Current Liabilities | - | - | - | - |
| Equity | ||||
| Common Stock Equity | $10,202,000 | $8,585,000 | $8,358,000 | $5,592,000 |
| Total Equity Gross Minority Interest | $10,202,000 | $8,585,000 | $8,358,000 | $8,881,000 |
| Stockholders Equity | $10,202,000 | $8,585,000 | $8,358,000 | $5,592,000 |
| Retained Earnings | $-143,138,000 | $-144,332,000 | $-144,406,000 | $-142,831,000 |
| Other Equity Interest | - | $1,000 | - | - |
| Gains Losses Not Affecting Retained Earnings | - | - | - | $0 |
| Other | ||||
| Ordinary Shares Number | $10,644,268 | $10,544,691 | $10,543,675 | $10,297,429 |
| Share Issued | $10,644,268 | $10,544,691 | $10,543,675 | $10,297,429 |
| Tangible Book Value | $8,961,000 | $7,261,000 | $6,947,000 | $4,008,000 |
| Invested Capital | $10,202,000 | $8,585,000 | $8,358,000 | $5,664,000 |
| Working Capital | $8,456,000 | $6,736,000 | $6,292,000 | $6,849,000 |
| Capital Lease Obligations | $1,063,000 | $1,411,000 | $1,836,000 | $1,021,000 |
| Total Capitalization | $10,202,000 | $8,585,000 | $8,358,000 | $5,593,000 |
| Additional Paid In Capital | $153,329,000 | $152,906,000 | $152,754,000 | $148,413,000 |
| Capital Stock | $11,000 | $10,000 | $10,000 | $10,000 |
| Common Stock | $11,000 | $10,000 | $10,000 | $10,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $672,000 | $1,063,000 | $1,390,000 | $705,000 |
| Current Capital Lease Obligation | $391,000 | $348,000 | $446,000 | $316,000 |
| Current Accrued Expenses | $1,354,000 | $521,000 | $758,000 | $268,000 |
| Goodwill | $759,000 | $759,000 | $759,000 | $759,000 |
| Net PPE | $1,127,000 | $1,538,000 | $1,959,000 | $1,100,000 |
| Accumulated Depreciation | $-1,064,000 | $-1,009,000 | $-962,000 | $-923,000 |
| Gross PPE | $2,191,000 | $2,547,000 | $2,921,000 | $2,023,000 |
| Leases | $88,000 | $88,000 | $88,000 | $13,000 |
| Other Properties | $1,920,000 | $2,276,000 | $2,650,000 | $1,827,000 |
| Machinery Furniture Equipment | $183,000 | $183,000 | $183,000 | $183,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $2,973,000 | $2,261,000 | $2,144,000 | $2,709,000 |
| Raw Materials | $259,000 | $354,000 | $326,000 | $422,000 |
| Minority Interest | - | $0 | $0 | $3,289,000 |
| Treasury Shares Number | - | - | $0 | - |
| Work In Process | - | - | $0 | $22,000 |
Fetched: 2026-06-23
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $1,645,000 | $-547,000 | $752,000 | $-3,371,000 |
| Operating Activities | ||||
| Operating Cash Flow | $1,645,000 | $-492,000 | $827,000 | $-3,234,000 |
| Cash Flow From Continuing Operating Activities | $1,645,000 | $-492,000 | $827,000 | $-3,234,000 |
| Operating Gains Losses | $5,000 | $-11,000 | - | $-60,000 |
| Investing Activities | ||||
| Investing Cash Flow | $0 | $-50,000 | $-75,000 | $-137,000 |
| Cash Flow From Continuing Investing Activities | $0 | $-50,000 | $-75,000 | $-137,000 |
| Capital Expenditure | - | $-55,000 | $-75,000 | $-137,000 |
| Net Other Investing Changes | - | - | - | - |
| Financing Activities | ||||
| Financing Cash Flow | $-5,000 | $-5,000 | $-79,000 | $34,000 |
| Cash Flow From Continuing Financing Activities | $-5,000 | $-5,000 | $-79,000 | $34,000 |
| Net Other Financing Charges | - | - | - | $157,000 |
| Issuance Of Capital Stock | - | - | - | - |
| Net Common Stock Issuance | - | - | - | - |
| Common Stock Issuance | - | - | - | - |
| Other | ||||
| Repayment Of Debt | $-5,000 | $-5,000 | $-79,000 | $-286,000 |
| Interest Paid Supplemental Data | $1,000 | $2,000 | $2,000 | $19,000 |
| End Cash Position | $5,400,000 | $3,760,000 | $4,307,000 | $3,634,000 |
| Beginning Cash Position | $3,760,000 | $4,307,000 | $3,634,000 | $6,973,000 |
| Changes In Cash | $1,640,000 | $-547,000 | $673,000 | $-3,337,000 |
| Net Issuance Payments Of Debt | $-5,000 | $-5,000 | $-79,000 | $-286,000 |
| Net Long Term Debt Issuance | $-5,000 | $-5,000 | $-79,000 | $-15,000 |
| Long Term Debt Payments | $-5,000 | $-5,000 | $-79,000 | $-15,000 |
| Net PPE Purchase And Sale | $0 | $-50,000 | $-75,000 | $-137,000 |
| Sale Of PPE | $0 | $5,000 | $0 | - |
| Purchase Of PPE | $0 | $-55,000 | $-75,000 | $-137,000 |
| Change In Working Capital | $-413,000 | $-1,554,000 | $488,000 | $432,000 |
| Change In Other Current Liabilities | $-343,000 | $-442,000 | $-342,000 | $-355,000 |
| Change In Other Current Assets | $0 | $36,000 | $-31,000 | $382,000 |
| Change In Payables And Accrued Expense | $1,283,000 | $-446,000 | $639,000 | $-743,000 |
| Change In Accrued Expense | $1,024,000 | $-226,000 | $506,000 | $-150,000 |
| Change In Payable | $259,000 | $-220,000 | $133,000 | $-593,000 |
| Change In Account Payable | $259,000 | $-220,000 | $133,000 | $-593,000 |
| Change In Prepaid Assets | $-35,000 | $-10,000 | $56,000 | $26,000 |
| Change In Inventory | $-685,000 | $-407,000 | $387,000 | $765,000 |
| Change In Receivables | $-633,000 | $-285,000 | $-221,000 | $357,000 |
| Changes In Account Receivables | $-633,000 | $-285,000 | $-221,000 | $357,000 |
| Other Non Cash Items | $356,000 | $447,000 | $342,000 | $353,000 |
| Stock Based Compensation | $296,000 | $153,000 | $1,052,000 | $982,000 |
| Asset Impairment Charge | $68,000 | $262,000 | $295,000 | $2,168,000 |
| Depreciation Amortization Depletion | $139,000 | $137,000 | $214,000 | $351,000 |
| Depreciation And Amortization | $139,000 | $137,000 | $214,000 | $351,000 |
| Amortization Cash Flow | $84,000 | $91,000 | $175,000 | $258,000 |
| Amortization Of Intangibles | $84,000 | $91,000 | $175,000 | $258,000 |
| Depreciation | $55,000 | $46,000 | $39,000 | $93,000 |
| Net Foreign Currency Exchange Gain Loss | $5,000 | $-6,000 | $0 | $-60,000 |
| Net Income From Continuing Operations | $1,194,000 | $74,000 | $-1,575,000 | $-7,106,000 |
| Income Tax Paid Supplemental Data | - | $0 | $0 | $0 |
| Provisionand Write Offof Assets | - | $0 | $11,000 | $-1,000 |
| Effect Of Exchange Rate Changes | - | - | $0 | $-2,000 |
| Proceeds From Stock Option Exercised | - | - | $0 | $163,000 |
| Net Short Term Debt Issuance | - | - | $-71,000 | $-271,000 |
| Short Term Debt Payments | - | - | $-71,000 | $-271,000 |
| Issuance Of Debt | - | - | - | - |
| Long Term Debt Issuance | - | - | - | - |
Fetched: 2026-06-23